Literature DB >> 22310660

Rb/E2F1 regulates the innate immune receptor Toll-like receptor 3 in epithelial cells.

Manabu Taura1, Mary Ann Suico, Kosuke Koyama, Kensei Komatsu, Rui Miyakita, Chizuru Matsumoto, Eriko Kudo, Ryusho Kariya, Hiroki Goto, Shunsuke Kitajima, Chiaki Takahashi, Tsuyoshi Shuto, Mitsuyoshi Nakao, Seiji Okada, Hirofumi Kai.   

Abstract

Tumor suppressor genes regulate the antiviral host defense through molecular mechanisms that are not yet well explored. Here, we show that the tumor suppressor retinoblastoma (Rb) protein positively regulates Toll-like receptor 3 (TLR3) expression, the sensing receptor for viral double-stranded RNA and poly(I · C). TLR3 expression was lower in Rb knockout (Rb(-/-)) mouse embryonic fibroblasts (MEF) and in mammalian epithelial cells transfected with Rb small-interfering RNA (siRNA) than in control cells. Consequently, induction of cytokines interleukin-8 and beta interferon after poly(I · C) stimulation was impaired in Rb(-/-) MEF and Rb siRNA-transfected cells compared to controls. TLR3 promoter analysis showed that Rb modulates the transcription factor E2F1, which directly binds to the proximal promoter of TLR3. Exogenous addition of E2F1 decreased TLR3 promoter activity, while Rb dose dependently curbed the effect of E2F1. Interestingly, poly(I · C) increased the Rb expression, and the poly(I · C)-induced TLR3 expression was impaired in Rb-depleted cells, suggesting the importance of Rb in TLR3 induction by poly(I · C). Together, these data indicated that E2F1 suppresses TLR3 transcription, but during immune stimulation, Rb is upregulated to block the inhibitory effect of E2F1 on TLR3, highlighting a role of Rb-E2F1 axis in the innate immune response in epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22310660      PMCID: PMC3318576          DOI: 10.1128/MCB.06454-11

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  61 in total

Review 1.  The E2F transcriptional network: old acquaintances with new faces.

Authors:  Desssislava K Dimova; Nicholas J Dyson
Journal:  Oncogene       Date:  2005-04-18       Impact factor: 9.867

2.  A comprehensive ChIP-chip analysis of E2F1, E2F4, and E2F6 in normal and tumor cells reveals interchangeable roles of E2F family members.

Authors:  Xiaoqin Xu; Mark Bieda; Victor X Jin; Alina Rabinovich; Mathew J Oberley; Roland Green; Peggy J Farnham
Journal:  Genome Res       Date:  2007-10-01       Impact factor: 9.043

3.  PKR, a p53 target gene, plays a crucial role in the tumor-suppressor function of p53.

Authors:  Cheol-Hee Yoon; Eun-Soo Lee; Dae-Seog Lim; Yong-Soo Bae
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-24       Impact factor: 11.205

Review 4.  The regulation of E2F by pRB-family proteins.

Authors:  N Dyson
Journal:  Genes Dev       Date:  1998-08-01       Impact factor: 11.361

5.  TLR3 induction by anticancer drugs potentiates poly I:C-induced tumor cell apoptosis.

Authors:  Manabu Taura; Ryosuke Fukuda; Mary Ann Suico; Ayaka Eguma; Tomoaki Koga; Tsuyoshi Shuto; Takashi Sato; Saori Morino-Koga; Hirofumi Kai
Journal:  Cancer Sci       Date:  2010-03-13       Impact factor: 6.716

6.  Rescue of p53 function by small-molecule RITA in cervical carcinoma by blocking E6-mediated degradation.

Authors:  Carolyn Ying Zhao; Laszlo Szekely; Wenjie Bao; Galina Selivanova
Journal:  Cancer Res       Date:  2010-04-15       Impact factor: 12.701

Review 7.  Rb/E2F: a two-edged sword in the melanocytic system.

Authors:  Ruth Halaban
Journal:  Cancer Metastasis Rev       Date:  2005-06       Impact factor: 9.264

8.  The transcription factor E2F1 and the SR protein SC35 control the ratio of pro-angiogenic versus antiangiogenic isoforms of vascular endothelial growth factor-A to inhibit neovascularization in vivo.

Authors:  G Merdzhanova; S Gout; M Keramidas; V Edmond; J-L Coll; C Brambilla; E Brambilla; S Gazzeri; B Eymin
Journal:  Oncogene       Date:  2010-07-19       Impact factor: 9.867

9.  Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence.

Authors:  Akinori Takaoka; Sumio Hayakawa; Hideyuki Yanai; Dagmar Stoiber; Hideo Negishi; Hideaki Kikuchi; Shigeru Sasaki; Kohzoh Imai; Tsukasa Shibue; Kenya Honda; Tadatsugu Taniguchi
Journal:  Nature       Date:  2003-07-31       Impact factor: 49.962

10.  Regulation of cell growth-dependent expression of mammalian CDC6 gene by the cell cycle transcription factor E2F.

Authors:  K Ohtani; A Tsujimoto; M Ikeda; M Nakamura
Journal:  Oncogene       Date:  1998-10-08       Impact factor: 9.867

View more
  17 in total

1.  COMMD1/Murr1 reinforces HIV-1 latent infection through IκB-α stabilization.

Authors:  Manabu Taura; Eriko Kudo; Ryusho Kariya; Hiroki Goto; Kouki Matsuda; Shinichiro Hattori; Kulthida Vaeteewoottacharn; Fiona McDonald; Mary Ann Suico; Tsuyoshi Shuto; Hirofumi Kai; Seiji Okada
Journal:  J Virol       Date:  2014-12-17       Impact factor: 5.103

2.  Simultaneous Transcriptional and Epigenomic Profiling from Specific Cell Types within Heterogeneous Tissues In Vivo.

Authors:  Hyun Cheol Roh; Linus T-Y Tsai; Anna Lyubetskaya; Danielle Tenen; Manju Kumari; Evan D Rosen
Journal:  Cell Rep       Date:  2017-01-24       Impact factor: 9.423

Review 3.  The RB tumor suppressor at the intersection of proliferation and immunity: relevance to disease immune evasion and immunotherapy.

Authors:  Jack Hutcheson; Agnieszka K Witkiewicz; Erik S Knudsen
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 4.  Emerging roles of p53 and other tumour-suppressor genes in immune regulation.

Authors:  César Muñoz-Fontela; Anna Mandinova; Stuart A Aaronson; Sam W Lee
Journal:  Nat Rev Immunol       Date:  2016-09-26       Impact factor: 53.106

Review 5.  Retinoblastoma tumor suppressor functions shared by stem cell and cancer cell strategies.

Authors:  Susumu Kohno; Shunsuke Kitajima; Nobunari Sasaki; Chiaki Takahashi
Journal:  World J Stem Cells       Date:  2016-04-26       Impact factor: 5.326

6.  Retinoblastoma protein potentiates the innate immune response in hepatocytes: significance for hepatocellular carcinoma.

Authors:  Jack Hutcheson; Ryan J Bourgo; Uthra Balaji; Adam Ertel; Agnieszka K Witkiewicz; Erik S Knudsen
Journal:  Hepatology       Date:  2014-08-28       Impact factor: 17.425

Review 7.  Cell-Cycle Regulators and Cell Death in Immunity.

Authors:  Sophia G Zebell; Xinnian Dong
Journal:  Cell Host Microbe       Date:  2015-10-14       Impact factor: 21.023

8.  Development of Therapeutic-Grade Small Interfering RNAs by Chemical Engineering.

Authors:  Jesper B Bramsen; Jørgen Kjems
Journal:  Front Genet       Date:  2012-08-20       Impact factor: 4.599

9.  Germline genetic contribution to the immune landscape of cancer.

Authors:  Rosalyn W Sayaman; Mohamad Saad; Vésteinn Thorsson; Donglei Hu; Wouter Hendrickx; Jessica Roelands; Eduard Porta-Pardo; Younes Mokrab; Farshad Farshidfar; Tomas Kirchhoff; Randy F Sweis; Oliver F Bathe; Carolina Heimann; Michael J Campbell; Cynthia Stretch; Scott Huntsman; Rebecca E Graff; Najeeb Syed; Laszlo Radvanyi; Simon Shelley; Denise Wolf; Francesco M Marincola; Michele Ceccarelli; Jérôme Galon; Elad Ziv; Davide Bedognetti
Journal:  Immunity       Date:  2021-02-09       Impact factor: 31.745

Review 10.  Macrophages, inflammation, and tumor suppressors: ARF, a new player in the game.

Authors:  Paqui G Través; Alfonso Luque; Sonsoles Hortelano
Journal:  Mediators Inflamm       Date:  2012-12-18       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.